In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Demand is high for lab space in ...

Alisha Hines graduated from an eight-week program in biomanufacturing and life sciences earning what's known as a "microcredential." (Jesse Costa/WBUR) On a recent afternoon at Northeastern University ...

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...

Redwood LIFE comprises of 20 buildings totaling 1,006,092 square feet and is a key part of the tech and life science cluster thriving in and around San Francisco. The campus, located in Redwood City, ...

Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...

Fusing a world-class ecosystem with cutting-edge technology, the UK is setting a new standard for innovation in life sciences. Invigorated by the UK government’s 10-year Modern Industrial Strategy, ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...